作者: Hagop M. Kantarjian , Michael J. Keating , Ronald S. Walters , Terry L Smith , Kenneth B. McCredie
DOI: 10.1002/1097-0142(19870401)59:7<1258::AID-CNCR2820590705>3.0.CO;2-G
关键词:
摘要: The effect of maintenance chemotherapy on remission duration was analyzed in 39 70 patients (56%) with acute promyelocytic leukemia (APL) who achieved complete induction chemotherapy. Overall, the median 26 months, a 3-year rate 42%. significantly higher received 6-mercaptopurine and methotrexate (POMP) during maintenance, compared those did not (56% versus 30%; P less than 0.01), long-term therapy (P 0.01). A multivariate regression analysis selected POMP to be only statistically significant factor associated duration. type is important overall prognosis APL, should investigated further.